Table 1. OP-NT Hybrid Peptides Designed and Investigated in the Present Studya.
| compound number | sequence |
|---|---|
| 3 | H-Dmt-d-Arg-Aba-β-Ala-Arg-Arg-Pro-Tyr-Tle-Leu-OH |
| 4 | H-Dmt-d-Arg-Aba-β-Ala-Lys-Lys-Pro-Tyr-Tle-Leu-OH |
| 5 | H-Dmt-d-Arg-Aba-β-Ala-Arg-Arg-Pro-Dmt-Tle-Leu-OH |
| 6 | H-Dmt-d-Arg-Aba-β-Ala-Lys-Lys-Pro-Dmt-Tle-Leu-OH |
| 7 | H-Dmt-d-Arg-Aba-β-Ala-β3hArg-Arg-Pro-Dmt-Tle-Leu-OH |
| 8 | H-Dmt-d-Arg-Aba-β-Ala-β3hLys-Lys-Pro-Dmt-Tle-Leu-OH |
| 9 | H-Dmt-d-Arg-Aba-β-Ala-Arg-Arg-Pro-(6-OH)Tic-Tle-Leu-OH |
| 10 | H-Dmt-d-Arg-Aba-β-Ala-Lys-Lys-Pro-(6-OH)Tic-Tle-Leu-OH |
| 11 | H-Dmt-d-Arg-Aba-β-Ala-Arg-Arg-Pro-m-Tyr-Tle-Leu-OH |
| 12 | H-Dmt-d-Arg-Aba-β-Ala-Lys-Lys-Pro-m-Tyr-Tle-Leu-OH |
a
All sequence modifications are highlighted in bold.